Poitras Center to fuel early careers of 50 young scientists dedicated to psychiatric disorders research
Patricia and James Poitras ’63 provide fellowships for graduate students and postdocs who will shape the future of mental health research.
New gift expands mental illness studies at Poitras Center for Psychiatric Disorders Research
A commitment from longtime supporters Patricia and James Poitras ’63 initiates multidisciplinary efforts to understand and treat complex psychiatric disorders.
Understanding why autism symptoms sometimes improve amid fever
With support from The Marcus Foundation, an MIT neuroscientist and a Harvard Medical School immunologist will study the “fever effect” in an effort to devise therapies that mimic its beneficial effects.
From molecular to whole-brain scale in a simple animal, study reveals serotonin’s effects
With full genetic control and visibility into neural activity and behavior, MIT scientists map out chemical’s role in behavior.
Study shows fragile X treatment can incur resistance, suggests ways around it
While the brain acquires resistance to continuous treatment with mGluR5 inhibitor drugs, lasting effects may still arise if dosing occurs intermittently and during a developmental-critical period.
A new technique for correcting disease-causing mutations
Novel method, developed by McGovern Institute researchers, may lead to safer, more efficient gene therapies.
Investigating the embattled brain
Combat veteran and PhD candidate Omar Rutledge drives research on post-traumatic stress disorder.
Alumnus gives MIT $4.5 million to establish the Broderick Fund for Phytocannabinoid Research
Gifts to MIT and Harvard Medical School totaling $9 million will fund independent research on cannabinoid’s influence on brain health and behavior.
Deep stimulation improves cognitive control by augmenting brain rhythms
Finding could improve development of personalized psychiatric treatments.
Fikile Brushett and Florence Wagner named to Chemical and Engineering News “Talented 12”
MIT affiliates recognized for their innovative approaches to energy storage and drug discovery.
How one gene contributes to two diseases
Neuroscientists unravel Shank3 gene’s role in autism and schizophrenia.
Temple Grandin: Look at what people can do, not what they can’t
In talks at MIT, noted behavioral expert suggests encouraging skills of people with autism.
MIT researchers find where visual memories are made
Discovery could lead to new treatments for cognitive disorders including autism and schizophrenia.
Autism as a disorder of prediction
Researchers suggest autism stems from a reduced ability to make predictions, leading to anxiety.
$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research
Transformative partnership with Ted Stanley will spur researchers to reveal biology of psychiatric disorders.